98%
921
2 minutes
20
Background: Cases of exacerbation of pre-existing neuromuscular diseases induced by immune checkpoint inhibitors (ICIs) have rarely been reported because patients with autoimmune diseases have generally been excluded from ICI therapy due to the increased risk of exacerbation. We describe the first case of an elderly patient who experienced exacerbation of a previously undiagnosed sporadic inclusion body myositis (sIBM), the most common myopathy in the geriatric population, which was triggered by anti-programmed cell death-1 therapy.
Case Presentation: A 75-year-old man who was receiving pembrolizumab presented with limb weakness. Three years prior, he had noticed slowly progressive limb weakness, but he received no diagnosis. After the first infusion of pembrolizumab, his creatine kinase (CK) levels had increased. The neurological examination and muscle biopsy findings confirmed the diagnosis of sIBM and suggested exacerbation of sIBM induced by pembrolizumab. After the patient's CK levels decreased, pembrolizumab was restarted. The tumor progressed after its treatment with pembrolizumab. The patient died after 15 months of follow-up.
Conclusions: In patients with slowly progressive limb weakness, sIBM should be explored before ICI therapy. In addition, if patients show high CK levels after ICI introduction, it is necessary to confirm whether they have sIBM in order to avoid unnecessary immunosuppressive therapies and assess whether they can tolerate ICI reintroduction.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493364 | PMC |
http://dx.doi.org/10.1186/s41927-020-00144-5 | DOI Listing |
Mil Med
September 2025
Soldier Centered Medical Home-CAB, Desmond Doss Health Clinic, Wahiawa, Hawaii, HI 96786, United States.
Guillain-Barré Syndrome (GBS) is an acute immune-mediated inflammatory demyelinating polyradiculopathy of the peripheral nerves often provoked by a preceding upper respiratory or gastrointestinal infection. Guillain-Barré Syndrome usually presents with symmetrical lower limb ascending weakness and decreased deep tendon reflexes. Here, we describe a case of an uncommon presentation of GBS presenting with upper extremity neuropathy and cranial nerve palsy in a 36-year-old Caucasian Army pilot.
View Article and Find Full Text PDFGeroscience
September 2025
Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, WI, USA.
Degenerative cervical myelopathy (DCM) is a leading cause of non-traumatic spinal cord disorders in older adults. Gait instability and balance dysfunction are common in DCM, even in the absence of clinically evident lower limb weakness. We hypothesized that subclinical weakness, measured through maximal voluntary isometric contractions (MVICs) of the knee extensors and ankle plantar flexors, is associated with impaired gait and balance in individuals with DCM.
View Article and Find Full Text PDFJ Diabetes Investig
September 2025
Department of Rehabilitation, Hiroshima University Hospital, Hiroshima, Japan.
Purpose: Lower limb muscle strength is often reduced in patients with type 2 diabetes and is associated with a lower quality of life and poorer walking ability. Diabetic peripheral neuropathy (DPN) may contribute to muscle weakness, though evidence is inconsistent. No meta-analysis has specifically examined the effect of DPN on lower limb muscle strength.
View Article and Find Full Text PDFBMJ Case Rep
September 2025
Department of Neurology, Brown University Warren Alpert Medical School, Providence, Rhode Island, USA.
Monomelic amyotrophy (MMA) is a lower motor neuron predominant disorder affecting an upper limb, which can mimic amyotrophic lateral sclerosis (ALS). It often presents with unilateral, distal upper limb weakness and atrophy, whose trajectory is one of an initial period of progression followed by a prolonged plateau, as opposed to the typically relentless progression as is seen in ALS. This case report describes a novel observation of a patient with MMA with an unexplained ipsilateral partial Horner's syndrome (miosis and ptosis).
View Article and Find Full Text PDFJ Am Med Dir Assoc
September 2025
Department of Health Sciences, Ribeirão Preto School of Medicine, University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil. Electronic address:
Objectives: To investigate the association among 5 clinical functional performance tests-single-leg stance, gait speed, tandem gait, Timed Up and Go (TUG), and forward step- as indicators of functional decline in older adults, and to examine whether these associations vary across different age groups.
Design: Cross-sectional study.
Setting And Participants: Data were collected from 191 community-dwelling older adults, stratified into 4 age groups: 60-64, 65-69, 70-74, and 75-79 years.